Navigation Links
Surgical technique in Spain enables extirpation of benign tumors of the pancreas
Date:2/3/2009

This release is available in Spanish.

This minimally invasive procedure, pioneering in Spain, has been developed by a team of surgeons at the University Hospital of Navarra, which brings together the greatest experience worldwide in this technique.

The results obtained in patients were recently published in the specialised surgery journal of greatest international impact, Annals of Surgery. It is the highest number of patients operated on using laparoscopic central pancreatectomy and that has been published in scientific literature worldwide. The specialists who took part in the study and who undertook the surgical technique are Doctors Fernando Pardo, Fernando Rotellar and Custodia Montiel, surgeons at the University Hospital of Navarra

As Doctor Pardo, Director of the Hepatobiliopancreatic Surgery service states, this technique has been recognised as a feasible procedure that reduces complications and hospitalisation periods, in a highly specific pancreatic pathology. The main achievement is having managed to devise a laparoscopic surgery technique for operations which to date has only been possible through open surgery. This new laparoscopic method is much less invasive and enables a large part of the gland to be conserved, and thus avoids the appearance of post-operative diabetes.

Complex technique - excellent results

The results of the laparoscopic central pancreatectomy have been excellent, according to Doctor Rotellar, and can even exceed those achieved by open surgery. According to this specialist, the laparoscopic technique reduces complications compared to open surgery. The period of hospitalisation is reduced from the average of ten days with the conventional procedure to four days with laparoscopy. The much lower rates for side effects also bear on reduced hospitalisation periods.

The tumours that these operations target are mainly neuroendocrine or cystic tumours of the pancreas that are benign or of low malignant potential. These lesions are diagnosed with greater frequency amongst young women, with an average age of 30, states Doctor Rotellar. Thus, the principal goal of this procedure is to obtain the optimum precision surgery in such a way that we are able to preserve the pancreas to the maximum. This is why laparoscopic central pancreatectomy is not suitable for tumours of poorer prognosis where it is paramount to operate radically in order to avoid a future regeneration of the tumour.

The importance of this surgical technique lies in managing to extirpate the minimum portion possible of the pancreas and, consequently, avoid the risk of the patient developing an intolerance to glucose or diabetes, besides any digestive problems that may arise from the lack of pancreatic enzymes, pointed out Doctor Pardo.

The surgeon also stated that laparoscopic central pancreatectomy is a pioneering technique, given its complex nature (after extirpating a portion of the pancreas, an anastomosis or union of the pancreatic duct with the intestine is carried out by laparoscopy). This joining to the intestine is necessary for the pancreas to be able to secrete its juices into it and, thus, it is a highly delicate operation.


'/>"/>

Contact: Oihane Lakar
oihane@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. Pioneer Surgical Technology Hires Vice President of New Business Development
3. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
4. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
5. Revolutionary HD Surgical Footage from North Shore-LIJ Surgeon to be Broadcast for the First Time on ABCs 20/20, National Geographic Channel
6. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
7. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
8. Study finds limiting work hours for surgical residents enhances training
9. STAAR Surgical Reports Operational Progress
10. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
11. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: